Metoprolol for Migraine Prevention: Efficacy and Mechanism

Metoprolol (a β₁‑selective beta‑blocker) is a first‑line preventive medication for episodic migraine, supported by Level A evidence (AAN/AHS guidelines).

Mechanism

  • Blocks β‑adrenergic receptors → reduces catecholamine‑induced cerebral vasodilation and neuronal excitability.
  • May stabilize cortical spreading depression (CSD) and modulate trigeminovascular system.
  • Central effects: crosses blood‑brain barrier; may influence serotonin and noradrenaline pathways.

Dosing and Efficacy

  • Typical dose: 50–200 mg/day (divided or extended‑release).
  • ~50% of patients achieve ≥50% reduction in migraine frequency.
  • Onset: 4–8 weeks for full effect.

Considerations

  • Contraindicated in asthma, severe bradycardia, heart block, decompensated heart failure.
  • Side effects: fatigue, dizziness, depression, sexual dysfunction, exercise intolerance.
  • Not for acute attacks; use triptans/NSAIDs for breakthrough.

Discuss with a neurologist or headache specialist to determine if metoprolol fits your profile.

Migraine - Related Articles